Stock News Alert: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stock observed trading -16.10% off 52-week high price. On the other end, the stock has been noted 33.60% away from low price over the last 52-weeks. The stock disclosed a move of 0.44% away from 50 day moving average and 5.82% away from 200 day moving average. Moving closer, we can see that shares have been trading -3.12% off 20-day moving average. It has market cap of $15.40B.

On Feb. 3, 2020, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) declared the transition of Executive Vice President and Chief Financial Officer Dan Spiegelman.  Mr. Spiegelman will remain as an employee and senior advisor until September 1, 2020 to assist with the transition.  After that, he plans to pursue other interests and spend more time with family.  Brian R. Mueller, Senior Vice President, Finance and Chief Accounting Officer, has assumed the role of acting Chief Financial Officer.  The Company is initiating an internal and external search for the role of Chief Financial Officer.

On behalf of the entire Board and executive team, I would like to thank Dan for his important contributions and leadership during his tenure at the company.  Over the last seven and a half years, he has played an invaluable role in supporting the company’s growth, said Jean-Jaques Bienaimé, Chairman and Chief Executive Officer.  I am confident that Brian in the acting CFO role will help us build on the strong foundation established and seamlessly execute on our business strategies. A veteran at BioMarin with 17 years of experience at the company, Brian has a deep knowledge of our business and throughout his career here has been essential in laying the ground work for BioMarin’s continued long-term success.

The USA based company BioMarin Pharmaceutical Inc. moved with change of 0.61% to $84.01 with the total traded volume of 755376 shares in recent session versus to an average volume of 1.40M. The stock was observed in the 5 days activity at -0.72%. The one month performance of stock was -0.04%. BMRN’s shares are at 14.75% for the quarter and driving a -14.81% return over the course of the past year and is now at -0.64% since this point in 2018.  Right now the stock beta is 1.38. The average volatility for the week and month was at 2.38% and 2.54% respectively. There are 183.28M shares outstanding and 178.75M shares are floated in market.

Leave a Reply

Your email address will not be published. Required fields are marked *